CA2556557A1 - Method of evaluating the therapeutic potential of a vaccine for mucosal administration - Google Patents

Method of evaluating the therapeutic potential of a vaccine for mucosal administration Download PDF

Info

Publication number
CA2556557A1
CA2556557A1 CA002556557A CA2556557A CA2556557A1 CA 2556557 A1 CA2556557 A1 CA 2556557A1 CA 002556557 A CA002556557 A CA 002556557A CA 2556557 A CA2556557 A CA 2556557A CA 2556557 A1 CA2556557 A1 CA 2556557A1
Authority
CA
Canada
Prior art keywords
weeks
level
ige
solid phase
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002556557A
Other languages
English (en)
French (fr)
Inventor
Hans-Henrik Ipsen
Lise Lund Maerkedahl
Henrik Hugo Jacobi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
Alk Abello A/S
Hans-Henrik Ipsen
Lise Lund Maerkedahl
Henrik Hugo Jacobi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello A/S, Hans-Henrik Ipsen, Lise Lund Maerkedahl, Henrik Hugo Jacobi filed Critical Alk Abello A/S
Publication of CA2556557A1 publication Critical patent/CA2556557A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
CA002556557A 2004-02-26 2005-02-24 Method of evaluating the therapeutic potential of a vaccine for mucosal administration Abandoned CA2556557A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US54845404P 2004-02-26 2004-02-26
US60/548,454 2004-02-26
DKPA200400310 2004-02-26
DKPA200400310 2004-02-26
US55909504P 2004-04-02 2004-04-02
US60/559,095 2004-04-02
PCT/DK2005/000123 WO2005083385A2 (en) 2004-02-26 2005-02-24 Method of evaluating the therapeutic potential of a vaccine for mucosal administration

Publications (1)

Publication Number Publication Date
CA2556557A1 true CA2556557A1 (en) 2005-09-09

Family

ID=34915878

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002556557A Abandoned CA2556557A1 (en) 2004-02-26 2005-02-24 Method of evaluating the therapeutic potential of a vaccine for mucosal administration

Country Status (8)

Country Link
EP (1) EP1718974A2 (pt)
JP (1) JP2007524096A (pt)
AU (1) AU2005217696B2 (pt)
BR (1) BRPI0508078A (pt)
CA (1) CA2556557A1 (pt)
IL (1) IL177703A0 (pt)
RU (1) RU2006134031A (pt)
WO (1) WO2005083385A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005217696B2 (en) * 2004-02-26 2008-02-14 Alk-Abello A/S Method of evaluating the therapeutic potential of a vaccine for mucosal administration
EP1974746B1 (en) * 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
DK1974745T3 (da) 2007-03-28 2011-11-28 Alk Abello As Anvendelse af en adjuvansholdig allergivaccineformulering til subkutan administration
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
EP3457134B1 (en) 2016-05-13 2021-04-28 Applied Medical Enzyme Research Institute Corporation Method for collecting data to predict risk of developing allergies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0538266A1 (en) * 1991-05-10 1993-04-28 Alain Ladislas De Weck PROCEDURE FOR DETECTING AND PREPARING ANTI-IgE AUTOANTIBODIES AND USE OF THESE ANTIBODIES AS ACTIVE AGENTS IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS
US7888458B1 (en) * 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
DE69939260D1 (de) * 1998-06-24 2008-09-18 Alk Abello As Verfahren zum nachweis von antikörpern in flüssigen proben
WO2000040713A1 (en) * 1999-01-06 2000-07-13 Mcmaster University Method of preventing immune and hypersensitivity reactions
SE0004892D0 (sv) * 2000-12-29 2000-12-29 Pharmacia Diagnostics Ab Group 2 allergen specific IgE-Fabs and use thereof
GB0215710D0 (en) * 2002-07-05 2002-08-14 Isis Innovation Diagnostic method
UA62780A (en) * 2003-05-22 2003-12-15 Univ Oo Bohomolets Nat Medical Method for estimating efficiency of vaccination against diphtheria in children with allergic diathesis
AU2005217696B2 (en) * 2004-02-26 2008-02-14 Alk-Abello A/S Method of evaluating the therapeutic potential of a vaccine for mucosal administration

Also Published As

Publication number Publication date
AU2005217696B2 (en) 2008-02-14
WO2005083385A3 (en) 2005-11-17
IL177703A0 (en) 2006-12-31
EP1718974A2 (en) 2006-11-08
RU2006134031A (ru) 2008-04-10
BRPI0508078A (pt) 2007-07-17
JP2007524096A (ja) 2007-08-23
WO2005083385A2 (en) 2005-09-09
AU2005217696A1 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
US10471008B2 (en) Allergen dosage form
AU2005304107B2 (en) Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
AU2006310881B2 (en) Use of a liquid allergy vaccine formulation for oromucosal administration
AU2005217696B2 (en) Method of evaluating the therapeutic potential of a vaccine for mucosal administration
US7887821B2 (en) Process for producing an allergen extract
US20060171968A1 (en) Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
US20060002962A1 (en) Method of treating allergy and infection by eliciting an IGA antibody response
EP1834648B1 (en) Process for producing an allergen extract
US20050202030A1 (en) Method of evaluating the therapeutic potential of a vaccine for mucosal administration
ES2344915T3 (es) Procedimiento de tratamiento preventivo de alergia por administracion mucosal de una vacuna de alergia.
MXPA06009737A (es) Metodo para evaluar el potencial terapeutico de una vacuna de administracion por la mucosa

Legal Events

Date Code Title Description
FZDE Discontinued